Skip to main content
TipRanks
Go Ultimate75% OFF

Canopy Growth (CGC) Stock Price & Analysis

11,349 Followers

CGC Stock Chart & Stats

$0.50-$0.03(-5.65%)
At close: 4:00 PM EST
$0.5$0.75$1Aug 24Sep 8Sep 21Oct 5Oct 19Nov 2Nov 16
Day’s Range
$0.50 - $0.54
52-Week Range
$0.50 - $2.38
Previous Close
$0.53
Volume
N/A
Average Volume (3M)
2.82M
Market Cap
$241.48M
Enterprise Value
$494.26M
Total Cash (Recent Filing)
$319.79M
Total Debt (Recent Filing)
$281.44M
Price to Earnings (P/E)
―
Beta
1.41
Next Earnings
Feb 05, 2027 (Est.)
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Broad Revenue Growth

Broad-based revenue growth indicates improving demand across Canopy’s operating portfolio rather than reliance on one product or market. Continued gains in cannabis, medical, adult-use, and international channels could improve scale, strengthen brand reach, and support operating leverage over the next several quarters.

European Market Expansion

End-to-end EU GMP certification creates a durable platform for supplying regulated European markets and broadening beyond flower into additional patient-ready formats. This supports compliance, market access, product diversification, and potentially more consistent international growth as distribution expands.

Liquidity And Synergies

Substantial liquidity gives Canopy time to fund operations and execute cultivation, manufacturing, and distribution improvements while reducing immediate financing pressure. The targeted MTL synergies could also lower the cost base and improve earnings quality if delivered within the planned timeframe.

Bears Say

Persistent Losses And Cash Burn

Deep operating losses and negative operating and free cash flow show that the business is not yet self-funding. Continued cash consumption can constrain investment, increase reliance on available liquidity, and make the transition to sustainable profitability dependent on successful execution of planned improvements.

Gross Margin Pressure

The reimbursement-rate reduction directly pressured consolidated gross margin and demonstrates how policy-linked pricing can affect profitability in the medical channel. Unless pricing, mix, or operating efficiency offsets the impact, lower margins could limit conversion of revenue growth into durable earnings.

High Cultivation Costs

A structurally higher cultivation cost position can weaken competitiveness in a market where pricing and product affordability influence demand. Canopy’s strategy relies on higher-quality flower and better asset utilization, but those benefits must offset the cost disadvantage to support lasting margin improvement.

Canopy Growth News

CGC FAQ

What was Canopy Growth’s price range in the past 12 months?
Canopy Growth lowest stock price was $0.50 and its highest was $2.38 in the past 12 months.
What is Canopy Growth’s market cap?
Canopy Growth’s market cap is $241.48M.
When is Canopy Growth’s upcoming earnings report date?
Canopy Growth’s next earnings report is estimated for Feb 05, 2027 (not yet confirmed), which is in 78 days.
How were Canopy Growth’s earnings last quarter?
Canopy Growth released its earnings results on Nov 06, 2026. The company reported -$0.07 earnings per share for the quarter, missing the consensus estimate of -$0.027 by -$0.043.
Is Canopy Growth overvalued?
According to Wall Street analysts Canopy Growth’s price is currently Undervalued.
Does Canopy Growth pay dividends?
Canopy Growth does not currently pay dividends.
What is Canopy Growth’s EPS estimate?
Canopy Growth’s EPS estimate is -0.04.
How many shares outstanding does Canopy Growth have?
Canopy Growth has 423,352,660 shares outstanding.
What happened to Canopy Growth’s price movement after its last earnings report?
Canopy Growth reported an EPS of -$0.07 in its last earnings report, missing expectations of -$0.027. Following the earnings report the stock price went down -3.556%.
Which hedge fund is a major shareholder of Canopy Growth?
Currently, no hedge funds are holding shares in CGC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology